Entrada Therapeutics
TRDA
#7446
Rank
$0.42 B
Marketcap
$11.04
Share price
6.98%
Change (1 day)
-48.70%
Change (1 year)

Entrada Therapeutics (TRDA) - Total debt

Total debt on the balance sheet as of September 2025 : $52.4 Million USD

According to Entrada Therapeutics's latest financial reports the company's total debt is $52.4 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Entrada Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$59.2 M-13.22%
2023-12-31$68.23 M163.07%
2022-12-31$25.93 M
2021-12-31N/A